+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemodialysis Market by Type, Product & Service, and End User - Global Opportunity Analysis and Industry Forecast, 2018-2025

  • ID: 4612777
  • Report
  • July 2018
  • Region: Global
  • 240 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Cantel Medical Corp.
  • DaVita, Inc.
  • Diaverum
  • Gambro
Hemodialysis is a medical procedure used to remove waste from the blood of patients with chronic or acute kidney failure. The waste removal helps to maintain electrolyte balance in the patient’s body. The procedure works similar to an artificial kidney by filtering the blood through a device called the hemodialyzer. It also prevents accumulation of salts and wastes in blood, which may lead to poisoning. The global hemodialysis market was valued at $71,501 million in 2017 and is expected to reach $99,747 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.



The global hemodialysis market is expected to grow, owing to the increase in geriatric population and incidence of renal diseases, especially end stage renal disease (ESRD). In addition, increase in funding for improved dialysis products and services, rise in incidence of diabetes and hypertension, and shortage of kidneys for transplantation are expected to further propel the market growth. Although the hemodialysis market continues to grow, certain factors hamper the growth of this market. The complications and risks associated with the procedure of hemodialysis, such as severe anemia and fluid overload, drag the market growth. In addition, product recalls in recent years also have a negative impact over the market growth. Conversely, technological advancements leading to better adoption and opportunities in emerging economies are anticipated to offer growth opportunities for the global hemodialysis market.

The hemodialysis market is segmented on the basis of type, product and service, end user, and region. On the basis of type, it is categorized into conventional (3 times per week), daily (6 days a week), and nocturnal (3–6 nights per week). According to product and service, it is categorized into equipment, consumable, drug, and service.

By end user, it is divided into in-center dialysis and home dialysis. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), Asia-Pacific (Japan, China, Singapore, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis of the overall market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global hemodialysis market.
Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
An in-depth analysis based on region is provided to understand the regional market and facilitate the strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By type

Conventional (3 times per week)
Daily (6 days a week)
Nocturnal (3–6 nights per week)

By product and service

Equipment
Consumable
Drug
Service

By end user

In-center dialysis
Home dialysis

By region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

The list of key players operating in this market includes:

Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International, Inc.
Cantel Medical Corp.
DaVita, Inc.
Diaverum
Fresenius Medical Care AG & Co. KGaA
Nikkiso Co., Ltd.
Nipro Corporation
NxStage Medical, Inc.

The OTHER PLAYERS included in the value chain analysis (and not included in the report) include:

Gambro
Satellite Healthcare, Inc.
MEDIVATORS, Inc.
Frequently Asked Questions about the Global Hemodialysis Market

What is the estimated value of the Global Hemodialysis Market?

The Global Hemodialysis Market was estimated to be valued at $71501.0 million in 2017.

What is the growth rate of the Global Hemodialysis Market?

The growth rate of the Global Hemodialysis Market is 4.2%, with an estimated value of $99747.0 million by 2025.

What is the forecasted size of the Global Hemodialysis Market?

The Global Hemodialysis Market is estimated to be worth $99747.0 million by 2025.

Who are the key companies in the Global Hemodialysis Market?

Key companies in the Global Hemodialysis Market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Inc., Cantel Medical Corp., DaVita, Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd. and NxStage Medical, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Cantel Medical Corp.
  • DaVita, Inc.
  • Diaverum
  • Gambro

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Clinical trials
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase in funding for improved dialysis products and services
3.4.1.2. Increase in the number of ESRD patients
3.4.1.3. Rise in incidence of diabetes and hypertension
3.4.1.4. Shortage of kidneys for transplantation
3.4.2. Restraints
3.4.2.1. Risks and complications associated with dialysis
3.4.2.2. Product recall
3.4.3. Opportunities
3.4.3.1. Technological advancements leading to better adoption
3.4.3.2. Growth opportunities in emerging economies
3.4.4. Impact Analyses
3.5. Patent analysis (2013-2018)
3.5.1. Patent analysis, by year
CHAPTER 4: HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Equipment
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Dialysis Machines
4.2.3.1. Market size and forecast
4.2.4. Hemodialysis Water Treatment Systems
4.2.4.1. Market size and forecast
4.2.5. Others hemodialysis equipment
4.2.5.1. Market size and forecast
4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country
4.3. Consumables
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.3. Dialyzers
4.3.3.1. Market size and forecast
4.3.4. Catheters
4.3.4.1. Market size and forecast
4.3.5. Other hemodialysis consumables
4.3.5.1. Market size and forecast
4.3.6. Market size and forecast, region
4.3.7. Market analysis, by country
4.4. Drugs
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Services
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: HEMODIALYSIS MARKET, BY TYPE
5.1. Overview
5.2. Conventional hemodialysis
5.2.1. Market analysis, by country
5.3. Short daily hemodialysis/daily hemodialysis
5.3.1. Market analysis, by country
5.4. Nocturnal hemodialysis
5.4.1. Market analysis, by country
CHAPTER 6: HEMODIALYSIS MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. hemodialysis market, by type
6.2.2.1.2. U.S. hemodialysis market, by product and service
6.2.2.1.3. U.S. hemodialysis market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada hemodialysis market, by type
6.2.2.2.2. Canada hemodialysis market, by product and service
6.2.2.2.3. Canada hemodialysis market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico hemodialysis market, by type
6.2.2.3.2. Mexico hemodialysis market, by product and service
6.2.2.3.3. Mexico hemodialysis market, by end user
6.2.3. North America hemodialysis market, by type
6.2.4. North America hemodialysis market, by product and service
6.2.5. North America hemodialysis market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany hemodialysis market, by type
6.3.2.1.2. Germany hemodialysis market, by product and service
6.3.2.1.3. Germany hemodialysis market, by end user
6.3.2.2. France
6.3.2.2.1. France hemodialysis market, by type
6.3.2.2.2. France hemodialysis market, by product and service
6.3.2.2.3. France hemodialysis market, by end user
6.3.2.3. UK
6.3.2.3.1. UK hemodialysis market, by type
6.3.2.3.2. UK hemodialysis market, by product and service
6.3.2.3.3. UK hemodialysis market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy hemodialysis market, by type
6.3.2.4.2. Italy hemodialysis market, by product and service
6.3.2.4.3. Italy hemodialysis market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain hemodialysis market, by type
6.3.2.5.2. Spain hemodialysis market, by product and service
6.3.2.5.3. Spain hemodialysis market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe hemodialysis market, by type
6.3.2.6.2. Rest of Europe hemodialysis market, by product and service
6.3.2.6.3. Rest of Europe hemodialysis market, by end user
6.3.3. Europe hemodialysis market, by type
6.3.4. Europe hemodialysis market, by product and service
6.3.5. Europe hemodialysis market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan hemodialysis market, by type
6.4.2.1.2. Japan hemodialysis market, by product and service
6.4.2.1.3. Japan hemodialysis market, by end user
6.4.2.2. China
6.4.2.2.1. China hemodialysis market, by type
6.4.2.2.2. China hemodialysis market, by product and service
6.4.2.2.3. China hemodialysis market, by end user
6.4.2.3. India
6.4.2.3.1. India hemodialysis market, by type
6.4.2.3.2. India hemodialysis market, by product and service
6.4.2.3.3. India hemodialysis market, by end user
6.4.2.4. Australia
6.4.2.4.1. Australia hemodialysis market, by type
6.4.2.4.2. Australia hemodialysis market, by product and service
6.4.2.4.3. Australia hemodialysis market, by end user
6.4.2.5. South Korea
6.4.2.5.1. South Korea hemodialysis market, by type
6.4.2.5.2. South Korea hemodialysis market, by product and service
6.4.2.5.3. South Korea hemodialysis market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific hemodialysis market, by type
6.4.2.6.2. Rest of Asia-Pacific hemodialysis market, by product and service
6.4.2.6.3. Rest of Asia-Pacific hemodialysis market, by end user
6.4.3. Asia-Pacific hemodialysis market, by type
6.4.4. Asia-Pacific hemodialysis market, by product and service
6.4.5. Asia-Pacific hemodialysis market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil hemodialysis market, by type
6.5.2.1.2. Brazil hemodialysis market, by product and service
6.5.2.1.3. Brazil hemodialysis market, by end user
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia hemodialysis market, by type
6.5.2.2.2. Saudi Arabia hemodialysis market, by product and service
6.5.2.2.3. Saudi Arabia hemodialysis market, by end user
6.5.2.3. South Africa
6.5.2.3.1. South Africa hemodialysis market, by type
6.5.2.3.2. South Africa hemodialysis market, by product and service
6.5.2.3.3. South Africa hemodialysis market, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA hemodialysis market, by type
6.5.2.4.2. Rest of LAMEA hemodialysis market, by product and service
6.5.2.4.3. Rest of LAMEA hemodialysis market, by end user
6.5.3. LAMEA hemodialysis market, by type
6.5.4. LAMEA hemodialysis market, by product and service
6.5.5. LAMEA hemodialysis market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Asahi Kasei Corporation.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. B. Braun Melsungen AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Baxter International Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Cantel Medical Corp.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.5. DaVita Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Diaverum.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product Portfolio
7.6.4. Key strategic moves and developments
7.7. Fresenius Medical Care AG & Co. KGaA
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Nikkiso Co., Ltd.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Nipro Corporation
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. NxStage Medical, Inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Cantel Medical Corp.
  • DaVita, Inc.
  • Diaverum
  • Gambro
According to a new report, titled, "HemodiAnalysis Market by Type, Product & Service, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025, the market was valued at $71,502 million in 2017, and is projected to reach $99,747 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

The function of kidneys is to remove waste products and excess fluid from the blood. If the kidneys do not function normally, this process is implemented by hemodiAnalysis. Waste products, such as urea and creatinine, are removed from the blood with the help of artificial and tural semipermeable membranes.

The major driving factors for the growth of the global hemodiAnalysis market are increase in the number of end-stage rel disease (ESRD) patients, rise in incidence of diabetes and hypertension, and increase in funding for improved diAnalysis products and services. Moreover, owing to lack of matching donors, diAnalysis is preferred over kidney transplant, which is expected to further fuel market growth. However, risks and complications associated with diAnalysis and product recall are expected to hamper market growth.

By product and service, the service segment accounted for approximately two-thirds share of the global hemodiAnalysis market in 2017. Furthermore, the nocturl segment is anticipated to grow at the highest rate of 4.9% during the forecast period.

Key Findings of the HemodiAnalysis Market:

North America occupied less than two-thirds share of the global hemodiAnalysis market in the year 2017.
The consumable segment is anticipated to grow with the highest CAGR throughout the forecast period.
Europe is anticipated to nearly occupy a one-third market share of the global hemodiAnalysis medicine market by 2025.
The Asia-Pacific region is anticipated to grow at the highest rate during the forecast period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to presence of a large population base along with a well-established healthcare infrastructure and technological advancements in patient care. However, Asia-Pacific is expected to grow at the highest CAGR of 6.6% from 2018 to 2025, owing to rise in government initiatives to establish new diAnalysis centers, increase in awareness related to diAnalysis products in the market, and increase in the number of independent diAnalysis centers.

The report provides an extensive competitive Analysis and profiles of the key market players, such as Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter Intertiol, Inc., Cantel Medical Corp., DaVita, Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, and NxStage Medical, Inc. The other players in the value chain (not included in the report) include Gambro, Satellite Healthcare, Inc., and MEDIVATORS, Inc.
Note: Product cover images may vary from those shown

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Cantel Medical Corp.
  • DaVita, Inc.
  • Diaverum
  • Fresenius Medical Care AG & Co. KGaA
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Gambro
  • Satellite Healthcare, Inc.
  • MEDIVATORS, Inc.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...